Kamux Corporation’s Interim Report for January 1–September 30, 2023: Revenue grew and adjusted operating profit increased significantly during the third quarter

HÄMEENLINNA, Finland, Nov. 10, 2023 /PRNewswire/ — This is a summary of Kamux Corporation’s Interim Report for January 1–September 30, 2023. The complete report is attached to this release and is also available at the company website at kamux.com. The figures in parentheses refer to the comparison period, i.e., the same period in the previous year,… Continue reading Kamux Corporation’s Interim Report for January 1–September 30, 2023: Revenue grew and adjusted operating profit increased significantly during the third quarter

Multi-Axis Sensor Market to Reach $3.1 Billion, Globally, by 2032 at 16.7% CAGR: Allied Market Research

The multi-axis sensor market is driven by factors such as rise in need for motion sensors in automotive industry and growing installation and adoption of MEMS accelerometers in high-end applications. WILMINGTON, Del., Nov. 10, 2023 /PRNewswire/ — Allied Market Research published a report, titled, “Multi-Axis Sensor Market By Type (MEMS Gyroscopes, MEMS Accelerometers, Digital Compass, Motion… Continue reading Multi-Axis Sensor Market to Reach $3.1 Billion, Globally, by 2032 at 16.7% CAGR: Allied Market Research

Trickster: The race for Christmas No.1 is no joke

LONDON, Nov. 13, 2023 /PRNewswire/ — Trickster, the Austrian singer and entrepreneur from Linz, releases his amped up and swinging mash-up of Christmas classics ‘Silent Night vs Santa Claus Is Coming To Town’ on Trickster Recordings through Absolute on 17 November 2023. Blending nostalgia and festive warmth, this is the Christmas cocktail you didn’t know you needed:… Continue reading Trickster: The race for Christmas No.1 is no joke

Global Sleep Apnea Market Analysis & Forecast to 2023-2033 with Profiles of Leading Players ResMed, Phillips Respironics, Fisher & Paykel Healthcare, Curative Medical and More

DUBLIN, Nov. 13, 2023 /PRNewswire/ — The “Global Sleep Apnea Market Analysis & Forecast to 2023-2033: Market By Product; By End-user; and by Region” report has been added to ResearchAndMarkets.com’s offering. The global sleep apnea market size was estimated to be USD 6.25 Billion in 2023 and is expected to reach at USD 13.8 Billion by… Continue reading Global Sleep Apnea Market Analysis & Forecast to 2023-2033 with Profiles of Leading Players ResMed, Phillips Respironics, Fisher & Paykel Healthcare, Curative Medical and More

Trickster : La course pour devenir le numéro 1 de Noël n’est pas une plaisanterie

LONDRES, 13 novembre 2023 /PRNewswire/ — Trickster, le chanteur et entrepreneur autrichien de Linz, sort son mash-up survolté et swinguant des classiques de Noël « Silent Night vs Santa Claus Is Coming To Town » sur Trickster Recordings par l’intermédiaire d’Absolute le 17 novembre 2023. Mélange de nostalgie et de chaleur festive, c’est le cocktail de Noël dont vous ne saviez pas que vous… Continue reading Trickster : La course pour devenir le numéro 1 de Noël n’est pas une plaisanterie

Emirates Orders Nearly 100 More Boeing Widebody Airplanes

DUBAI, United Arab Emirates, Nov. 13, 2023 /PRNewswire/ — Boeing [NYSE: BA] and Emirates announced today that the world’s largest 777 operator has placed an order for 90 777X airplanes, including 55 777-9 and 35 777-8 jets. The new order, which increases Emirates’ 777X family backlog to 205 planes, was announced during the Dubai Airshow at… Continue reading Emirates Orders Nearly 100 More Boeing Widebody Airplanes

Lingnan University study reveals unfair representation of MDW in mistreatment cases in Chinese-language media

HONG KONG, Nov. 13, 2023 /PRNewswire/ — Most Chinese-language media reports concerning migrant domestic workers (MDW) in Hong Kong fail to report their mistreatment factually, independently and critically, and focus on news appeal while neglecting the deeper roots of this important issue, related to power and the interplay of gender, race, ethnicity, and class, according… Continue reading Lingnan University study reveals unfair representation of MDW in mistreatment cases in Chinese-language media

China Life Insurance Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

BEIJING, Nov. 13, 2023 /PRNewswire/ — China Life Insurance Company Limited (the “Company“) (SSE: 601628; HKSE: 2628) announced today that the Company intends to deregister with the United States Securities and Exchange Commission (the “SEC“) and terminate its reporting obligations under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act“). The Company… Continue reading China Life Insurance Company Limited Intends to Deregister and Terminate Its Reporting Obligations Under the U.S. Securities Exchange Act of 1934

Artemis Aerospace investigates the growth of the aviation industry in India

As the aviation industry begins to take flight again after the static years of the pandemic, one country is striding ahead. Artemis Aerospace investigates India’s rise to the skies. WISTON, England, Nov. 13, 2023 /PRNewswire/ — The announcement earlier this year that the Air India Group has ordered 470 aircraft set the aviation industry alight with interest… Continue reading Artemis Aerospace investigates the growth of the aviation industry in India

Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease

International research collaboration between Harvard Medical School, Cambridge University and Mission Therapeutics CAMBRIDGE, England, Nov. 13, 2023 /PRNewswire/ — Mission Therapeutics (“Mission”), a clinical-stage biotech company developing first-in-class therapeutics targeting mitophagy, today announces the publication of a peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s Disease (PD) mouse model’ in… Continue reading Mission Therapeutics announces publication in Nature Communications outlining potential of experimental drug MTX325 as a disease-modifying therapy for Parkinson’s Disease